Literature DB >> 11748053

Role of activated platelets in excitation of cardiac afferents during myocardial ischemia in cats.

Liang-Wu Fu1, John C Longhurst.   

Abstract

Myocardial ischemia activates cardiac spinal afferents that mediate chest pain and excitatory reflex cardiovascular responses. Platelets are activated during myocardial ischemia and release 5-hydroxytryptamine, which stimulates abdominal spinal afferents. This study investigated the role of activated platelets in excitation of cardiac spinal afferents during ischemia. Platelet-rich plasma (PRP) and platelet-poor plasma (PPP) were obtained from cats and incubated with collagen (2 mg/ml) or thrombin (5 U/ml). We observed reduction of platelets in PRP indicative of platelet activation by collagen and thrombin, respectively. Activity of single-unit, ischemia-sensitive cardiac spinal afferents was recorded from the left sympathetic chain in anesthetized cats. Injection of 1.5 ml PRP + collagen (activated platelets) into the left atrium (LA) stimulated 12 of 13 cardiac afferents. PRP + saline (nonactivated platelets, LA) and PPP + collagen did not alter activity of these afferents. PRP + thrombin (1.5 ml, LA) stimulated eight of nine other cardiac afferents, whereas PPP + thrombin did not stimulate any of the nine afferents. Antiplatelet immune serum (1 ml/kg iv) significantly decreased circulating platelets as well as neutrophils (polymorphonuclear leukocytes, PMNs) in eight other cats, and in each animal, attenuated the ischemia-related increase in activity of cardiac afferents. Conversely, responses of five separate cardiac afferents to ischemia were not diminished after treatment with anti-PMN immune serum when concentration of circulating platelets was maintained by infusion of donated PRP despite the decrease in circulating PMNs. These data indicate activated platelets stimulate ischemia-sensitive cardiac spinal afferents and contribute to activation of these afferents during ischemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11748053     DOI: 10.1152/ajpheart.2002.282.1.H100

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Interactions between histamine and bradykinin in stimulation of ischaemically sensitive cardiac afferents in felines.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

2.  Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT(3) receptors.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

3.  Endogenous endothelin stimulates cardiac sympathetic afferents during ischaemia.

Authors:  Liang-Wu Fu; Zhi-Ling Guo; John C Longhurst
Journal:  J Physiol       Date:  2010-05-04       Impact factor: 5.182

4.  Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function.

Authors:  Francine Côté; Etienne Thévenot; Cécile Fligny; Yves Fromes; Michèle Darmon; Marie-Anne Ripoche; Elisa Bayard; Naima Hanoun; Francoise Saurini; Philippe Lechat; Luisa Dandolo; Michel Hamon; Jacques Mallet; Guilan Vodjdani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

5.  Undiscovered role of endogenous thromboxane A2 in activation of cardiac sympathetic afferents during ischaemia.

Authors:  Liang-Wu Fu; Zhi-Ling Guo; John C Longhurst
Journal:  J Physiol       Date:  2008-05-15       Impact factor: 5.182

6.  Bradykinin and thromboxane A2 reciprocally interact to synergistically stimulate cardiac spinal afferents during myocardial ischemia.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

Review 7.  Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target.

Authors:  Melanie Ziegler; Xiaowei Wang; Karlheinz Peter
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.